100%

Tirzepatide vs Retatrutide

Compare Tirzepatide and Retatrutide by category, route, half-life, molecular weight, approval status, reported effects, and educational safety context.

Side-by-side comparison table

Category
Weight Loss
Weight Loss
Route
Injectable
Injectable
Half-life
5 days
6 days
Molecular weight
4814 Da
4731 Da
Approval status
FDA-approved (Mounjaro, Zepbound)
Investigational
Reported effects
Powerful weight loss, A1c reduction, Lipid improvement
Major weight loss, Improved metabolism, Lipid effects

Evidence summary

How to read this comparison

This page compares database fields only. It does not rank which peptide is better, safer, stronger, or appropriate for any person.

Evidence strength can differ by molecule and indication. FDA-approved status, investigational status, cosmetic use, animal research, and in vitro research should not be treated as equivalent evidence.

Frequently asked questions

Is Tirzepatide stronger than Retatrutide?

Peptidic does not rank peptides by strength. The comparison focuses on visible database facts such as route, category, half-life, molecular weight, approval status, and cautious research context.

Can this comparison be used to choose a peptide?

No. Comparison pages are educational references only and are not treatment, dosing, sourcing, or personal-use recommendations.